Low-GI foods and certain nutrients linked to lower risk of AMD in US study

17 May 2009

A diet that includes key nutrients and low-glycemic index foods is likely to reduce risks for age-related macular degeneration, according  to the first study to analyze these factors in combination. Earlier  studies had revealed the AMD-protective effects of several nutrients and  of a low-glycemic index diet, but the latest study, conducted by a team  of US researchers, is the first to associate specific food patterns  with substantial AMD risk reductions.

Study participants whose diets included higher levels of protective  nutrients and of low-GI foods were at lowest risk for early and advanced  AMD. This eye disease affects the retina, the sensitive tissue at the  back of the eye that transmits images to the brain. Advanced AMD can  destroy the detailed, central vision people need to read, drive and  enjoy daily life.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight